Ash Attia

Thoratec Corp. develops, manufactures and markets proprietary medical devices used for circulatory support for the treatment of heart failure patients. The company's products include Ventricular Assist Devices, HeartMate Left Ventricular Assist System, HeartMate II Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device and Thoratec Implantable Ventricular Assist. It also manufactures and markets the CentriMag Acute Circulatory System, HeartMate II, PVAD, IVAD and for pediatric patients PediMag/PediVAS Acute Circulatory System. Its ventricular assist devices products primarily serve patients suffering from late-stage heart failure. Heart Failure is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. The company operates its business through the Cardiovascular group segment, which develops, manufactures mechanical circulatory products to support the cardiovascular systems of humans and to provide product-related services. Thoratec was founded in March 1976 and is headquartered in Pleasanton, CA.

TransMedics, Inc. manufactures and develops medical devices. It offers a portable warm blood perfusion system designed to maintain organs in a functioning state outside the human body during transport from organ donor to recipient. The firm’s products are used in heart, lung, liver, and kidney transplants. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.

St. Jude Medical Australia Pty Ltd. manufactures medical technology equipment. It offers Quadra Allure, Precision Xtra System, Urovysion, Polycose, and Pulmocare products. The company is headquartered in Sydney, Australia.

Ventracor Ltd. manufactures and markets a range of cardiac technology products. The company has developed an implantable blood pump, the VentrAssist left ventricular assist device, designed as therapy for patients in end stage heart failure. It also engages in the research, development, manufacture, clinical trials and commercialization of the VentrAssist LVAD and related technologies. Ventracor was founded in 1986 and is headquartered in Sydney, Australia.

Bionic Vision Technologies Pty Ltd. specializes in restoring functional vision for the blind. The private company is based in Carlton, Australia. The Australian company's retinal prosthesis system delivers visual information to the brain to improve the patient's awareness of external objects and surroundings. The CEO of the company is Ashraf Attia.